Higher cognitive performance is linked to an increased risk for future depression among people with depression in remission.

In everyday language, we use the term “depression” very casually. When something, anything, makes us sad, we might say, ...

Psychologists have developed a precision treatment approach for depression that gives patients individualized recommendations based on multiple characteristics, such as age and gender. Depression ...

Learn about how crop yield is defined and measured, its significance, how technology enhances yield efficiency, and get ...

A recent meta-analysis highlights that comorbid depression in type 2 diabetes mellitus is associated with a significant 0.30% ...

The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.

Low-dose buprenorphine significantly enhanced the antisuicidal effects of a single infusion of ketamine in patients with ...

A new, drug-free treatment for depression delivered eye-opening results that were as effective as one of the most commonly ...

Psilocybin has been proposed as a rapid-acting antidepressant (onset <2 weeks) with sustained effects (>6 weeks), but evidence from randomized clinical trials remains limited, particularly in the ...

Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the drug lives up to its hype.

In this study, the researchers examined how somatic symptoms are reported compared to other depressive symptoms in patients with ovarian cancer.

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...